Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03625752 · ClinicalTrials.gov registry record · NA

Optimization of NIBS for Diabetic Neuropathy Neuropathic Pain

A NA study of Chronic Pain and Diabetic Neuropathies, sponsored by Case Western Reserve University.

Active
Registry status
NA
Development phase
60
Enrollment target
2
Study locations

NCT03625752 is a NA study of Chronic Pain and Diabetic Neuropathies that is active but no longer recruiting, run by Case Western Reserve University. The registered enrollment target is 60 participants, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (92% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03625752, a NA study of Chronic Pain and Diabetic Neuropathies, is active but no longer recruiting, sponsored by Case Western Reserve University.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target
2
Study locations

Study Summary

The purpose of this study is to assess the effects of Transcranial Direct Current Stimulation (tDCS) in combination with Transcranial ultrasound (TUS) for the treatment of pain and functional limitations in subjects with Diabetic Neuropathic Pain.

Interventions

  • DEVICE Sham
  • DEVICE Active Comparator: Active tDCS + Active TUS

Study Locations (2)

Illinois

  • Ciro Ramos Estebanez - Chicago

Ohio

  • University Hospitals Cleveland Medical Center/ Dahms Clinical Research Unit - Cleveland

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2019-06-06
Est. Completion 2026-05-07
Phase NA

Sponsor

Case Western Reserve University

141 total trials

What the Registry Record Tells You About NCT03625752

The ClinicalTrials.gov registry entry for NCT03625752 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (92% lower). The listed sponsor is Case Western Reserve University, which has 141 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Chronic Pain appearing as the primary indexed condition, and to 2 interventions - of which Sham is the first listed.

NCT03625752 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Illinois, Ohio.

Frequently Asked Questions

What is clinical trial NCT03625752 about?

NCT03625752 is a clinical study titled "Optimization of NIBS for Diabetic Neuropathy Neuropathic Pain". The purpose of this study is to assess the effects of Transcranial Direct Current Stimulation (tDCS) in combination with Transcranial ultrasound (TUS) for the treatment of pain and functional limitations in subjects with Diabetic Neuropathic Pain.

What is the current status of trial NCT03625752?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2019-06-06. Estimated completion is 2026-05-07.

What conditions does trial NCT03625752 study?

This clinical trial studies the following conditions: Chronic Pain, Diabetic Neuropathies.

What interventions are being tested in trial NCT03625752?

The interventions under investigation include: Sham (DEVICE), Active Comparator: Active tDCS + Active TUS (DEVICE).

Who is sponsoring clinical trial NCT03625752?

This trial is sponsored by Case Western Reserve University, which has 141 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03625752 being conducted?

This trial has 2 study locations across Illinois, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.